Drug Discovery Informatics enables the users to deal with large volume of knowledge storage & management and processing & analysing the obtained results. These drug discovery informatics platforms use bioinformatics algorithms for processing bioscience data and uses various in silico models for analysing the info obtained. Success of a drug discovery experiment depends extensively on effectiveness of tools employed to assess varied aspects of medicine.
In silico tools used herein include modelling tools for determination of 3D structures of ligand and protein-ADMET assessment-affinity estimation in docking and drug-ligand interaction for pharmacological profiling. Large volume of knowledge procured by innovative methods and therefore the need for an efficient tool to research this data are anticipated to drive the market of drug discovery informatics within the coming years. In recent years, various collaborations are seen amongst the drug discovery informatics providers, which proves to be a serious opportunity within the market.
The global Drug Discovery Informatics market is segregated on the basis of Function as Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation, and Other functions. Based on Application the global Drug Discovery Informatics market is segmented in Drug Discovery and Drug Development. Based on End User the global Drug Discovery Informatics market is segmented in Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users.
Based on Solution, the global Drug Discovery Informatics market is segmented in Software and Services.
The global Drug Discovery Informatics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Drug Discovery Informatics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
ChemAxon, GVK Biosciences, Jubilant Biosys, Selvita, Certara, Infosys, Albany Molecular Research Inc., Boehringer Ingelheim GmBh, DiscoverX, Charles River Laboratories, and others are among the major players in the global Drug Discovery Informatics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Drug Discovery Informatics Market has been segmented as below:
Drug Discovery Informatics Market, By Function
Drug Discovery Informatics Market, By Application
Drug Discovery Informatics Market, By End User
Drug Discovery Informatics Market, By Solution
Drug Discovery Informatics Market, By Region
Drug Discovery Informatics Market, By Company
The report covers:
Report Scope:
The global Drug Discovery Informatics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Drug Discovery Informatics market share. Major industry players with significant revenue share include ChemAxon, GVK Biosciences, Jubilant Biosys, Selvita, Certara, Infosys, Albany Molecular Research Inc., Boehringer Ingelheim GmBh, DiscoverX, Charles River Laboratories, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Cholesterol Screening/ Cholesterol Lab Testing Services Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Drug Discovery Informatics Market, By Function
5.1 Introduction
5.2 Sequencing and Target Data Analysis
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Docking
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Molecular Modelling
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Library & Database Preparation
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Other functions
5.6.1 Market Overview
5.6.2 Market Size and Forecast
6. Drug Discovery Informatics Market, By Application
6.1 Introduction
6.2 Drug Discovery
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Drug Development
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Drug Discovery Informatics Market, By End User
7.1 Introduction
7.2 Pharmaceutical Companies
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Biotechnology Companies
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Contract Research Organization (CROs)
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Other End Users
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. Drug Discovery Informatics Market, By Solution
8.1 Introduction
8.2 Software
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Services
8.3.1 Market Overview
8.3.2 Market Size and Forecast
9. Drug Discovery Informatics Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Drug Discovery Informatics, By Function
9.2.2 North America Drug Discovery Informatics, By Application
9.2.3 North America Drug Discovery Informatics, By End User
9.2.4 North America Drug Discovery Informatics, By Solution
9.3 Europe
9.3.1 Europe Drug Discovery Informatics, By Function
9.3.2 Europe Drug Discovery Informatics, By Application
9.3.3 Europe Drug Discovery Informatics, By End User
9.3.4 Europe Drug Discovery Informatics, By Solution
9.4 Asia-Pacific
9.4.1 Asia-Pacific Drug Discovery Informatics, By Function
9.4.2 Asia-Pacific Drug Discovery Informatics, By Application
9.4.3 Asia-Pacific Drug Discovery Informatics, By End User
9.4.4 Asia-Pacific Drug Discovery Informatics, By Solution
9.5 Rest of the World
9.5.1 Rest of the World Drug Discovery Informatics, By Function
9.5.2 Rest of the World Drug Discovery Informatics, By Application
9.5.3 Rest of the World Drug Discovery Informatics, By End User
9.5.4 Rest of the World Drug Discovery Informatics, By Solution
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
(Overview, Key Financials, Recent Developments, Product and Service Offering)
11.1 ChemAxon
11.2 GVK Biosciences
11.3 Jubilant Biosys
11.4 Selvita
11.5 Certara
11.6 Infosys
11.7 Albany Molecular Research Inc.
11.8 Boehringer Ingelheim GmBh
11.9 DiscoverX
11.10 Charles River Laboratories
11.11 Covance
11.12 Collaborative Drug Discovery Inc.
11.13 Novo Informatics
11.14 UCB
11.15 Evotec among others.
The Drug Discovery Informatics Market has been segmented as below:
Drug Discovery Informatics Market, By Function
Drug Discovery Informatics Market, By Application
Drug Discovery Informatics Market, By End User
Drug Discovery Informatics Market, By Solution
Drug Discovery Informatics Market, By Region
Drug Discovery Informatics Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
